Skip to content

We Venture Capital

We Venture Capital is the corporate venture capital arm of Werfen, based in Barcelona, Spain. It invests in early-stage diagnostics startups and biotechnology companies focused on disrupting the diagnostics sector.

Founded
2023
Recorded stages
Seed, Series A, Series B
Recorded regions
Global

Online destinations

Find We Venture Capital online

Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.

Official links

Pages the organization runs itself.

Overview

We Venture Capital is the corporate venture arm of Werfen, a global leader in Specialized Diagnostics. Launched in September 2023, the organization focuses on investing in early-stage startups that are close to market entry or early scale-ups within the diagnostics sector. The firm targets next-generation diagnostics and emerging biotech solutions, seeking companies with innovative technology that addresses clear clinical unmet needs. We Venture Capital provides strategic support and leverages a global network to maximize the chances of success for its portfolio companies.

Focus

We Venture Capital invests in diagnostics start-ups, digital solutions, and life science tools that aim to disrupt the diagnostics arena. The organization targets next-generation diagnostics and emerging biotech solutions, seeking companies with innovative technology that addresses clear clinical unmet needs. They provide strategic support and leverage a global network to maximize the chances of success for their portfolio companies.

Support

We Venture Capital provides strategic support and leverages Werfen’s global network, scientific and technical expertise, and market access to maximize the chances of success for its portfolio companies.

Check your startup’s fit

Check your startup’s fit with We Venture Capital

Similar investors

Organizations that do similar work to We Venture Capital.

All investors
Deerfield Management logoInvestor

Deerfield Management is a New York City-based investment management firm specializing in healthcare investments, managing over $15 billion in assets across more than 200 companies. The firm focuses on both public and private investments in sectors such as biotechnology, medical devices, and digital health.

o2h group logoInvestor

Investing in the future of life sciences and technology.

HUMAN CAPITAL logoInvestor

Human Capital is a multi-stage venture capital firm that partners with exceptional founders to build companies addressing critical industry challenges. They focus on assembling high-caliber teams and deploying capital to support these ventures.

OrbiMed logoInvestor

OrbiMed is a healthcare-focused investment firm based in New York City, managing approximately $19 billion in assets. The firm invests across the healthcare spectrum, from early-stage startups to large multinational companies, with a focus on biopharmaceuticals and medical technologies.

Superscout Pro

Find faster. Show up verified. Keep your deals private.

$99a year, or $12 a month
Get Pro

Is this page right?Reviewed · How the research works

Something's off